StockCIK 1782223

Pyxis Oncology, Inc. (PYXS): Insider Trades and Fund Holdings

In the past 12 months, Pyxis Oncology, Inc. insiders reported 1 open-market purchase worth $0 and 0 sales worth $0.

1Insider buys, 12 months

$0Bought by insiders, 12 months

$0Sold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.

Recent PYXS insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 2	Oct 1	Gordonmd Global Investments LP10% owner	10% owner (ind.)	▲ BUY	5,517,000	n/a	n/a	+55%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Gordonmd Global Investments LP	10% owner	1	$0	0	$0	Oct 2, 2026

Tracked funds that report PYXS

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	772,232	$2.32M	0.00%	▼ −13.1%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →